SERA PROGNOSTICS, INC. Operating Lease Cost
SERA PROGNOSTICS, INC. (SERA) reported Operating Lease Cost of $117.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-12
- SERA PROGNOSTICS, INC. operating lease, cost for the quarter ending 2026-06-30 was $117.00K, a 26.42% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, cost for the quarter ending 2026-03-31 was $117.00K, a 26.42% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, cost for the quarter ending 2025-12-31 was $117.00K, a 26.42% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, cost for the quarter ending 2025-09-30 was $145.00K, a 8.81% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, cost for fiscal 2025 was $580.00K, a 8.81% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. operating lease, cost for fiscal 2024 was $636.00K, a 0.00% change from fiscal 2023.
- SERA PROGNOSTICS, INC. operating lease, cost for fiscal 2023 was $636.00K, a 26.19% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. operating lease, cost for fiscal 2022 was $504.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $117.00K 10-Q · filed 2026-08-12 | $235.00K 10-Q · filed 2026-08-12 | $351.00K derived: sum of 3 quarters · filed 2026-08-12 | $496.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $117.00K 10-Q · filed 2026-05-06 | $234.00K derived: sum of 2 quarters · filed 2026-05-06 | $379.00K derived: sum of 3 quarters · filed 2026-05-06 | $538.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $262.00K derived: sum of 2 quarters · filed 2026-03-18 | $421.00K derived: sum of 3 quarters · filed 2026-08-12 | $580.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $145.00K 10-Q · filed 2025-11-13 | $304.00K derived: sum of 2 quarters · filed 2026-08-12 | $463.00K 10-Q · filed 2025-11-13 | $622.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $159.00K 10-Q · filed 2026-08-12 | $318.00K 10-Q · filed 2026-08-12 | $477.00K derived: sum of 3 quarters · filed 2026-08-12 | $636.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $159.00K 10-Q · filed 2026-05-06 | $318.00K derived: sum of 2 quarters · filed 2026-05-06 | $477.00K derived: sum of 3 quarters · filed 2026-05-06 | $636.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $318.00K derived: sum of 2 quarters · filed 2026-03-18 | $477.00K derived: sum of 3 quarters · filed 2026-03-18 | $636.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $159.00K 10-Q · filed 2025-11-13 | $318.00K derived: sum of 2 quarters · filed 2025-11-13 | $477.00K 10-Q · filed 2025-11-13 | $636.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $159.00K 10-Q · filed 2025-08-06 | $318.00K 10-Q · filed 2025-08-06 | $477.00K derived: sum of 3 quarters · filed 2025-08-06 | $636.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $159.00K 10-Q · filed 2025-05-07 | $318.00K derived: sum of 2 quarters · filed 2025-05-07 | $477.00K derived: sum of 3 quarters · filed 2025-05-07 | $636.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $318.00K derived: sum of 2 quarters · filed 2025-03-19 | $477.00K derived: sum of 3 quarters · filed 2025-03-19 | $636.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $159.00K 10-Q · filed 2024-11-06 | $318.00K derived: sum of 2 quarters · filed 2024-11-06 | $477.00K 10-Q · filed 2024-11-06 | $632.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $159.00K 10-Q · filed 2024-08-07 | $318.00K 10-Q · filed 2024-08-07 | $473.00K derived: sum of 3 quarters · filed 2024-08-07 | $589.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $159.00K 10-Q · filed 2024-05-08 | $314.00K derived: sum of 2 quarters · filed 2024-05-08 | $430.00K derived: sum of 3 quarters · filed 2024-05-08 | $546.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $271.00K derived: sum of 2 quarters · filed 2024-03-20 | $387.00K derived: sum of 3 quarters · filed 2024-03-20 | $504.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $116.00K 10-Q · filed 2023-11-08 | $232.00K derived: sum of 2 quarters · filed 2023-11-08 | $349.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $116.00K 10-Q · filed 2023-08-09 | $233.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $116.00K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |